Reversal of Human Immunodeficiency Virus Type 1 IIIB to a Neutralization-Resistant Phenotype in an Accidentally Infected Laboratory Worker with a Progressive Clinical Course
Open Access
- 1 March 2001
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 75 (5) , 2246-2252
- https://doi.org/10.1128/jvi.75.5.2246-2252.2001
Abstract
The role of humoral immunity in controlling human immunodeficiency virus type 1 (HIV-1) is still controversial. The resistance of primary HIV-1 variants to neutralization by antibodies, sera from HIV-1-infected patients, and soluble CD4 protein has been suggested to be a prerequisite for the virus to establish persistence in vivo. To further test this hypothesis, we studied the neutralization sensitivity of two IIIB/LAV variants that were isolated from a laboratory worker who accidentally was infected with the T-cell-line-adapted neutralization-sensitive IIIB isolate. Compared to the original virus in the inoculum, the reisolated viruses showed an increased resistance to neutralization over time. The ratio of nonsynonymous to synonymous nucleotide substitutions in the envelope gene pointed to strong positive selection. The emergence of neutralization-resistant HIV preceded disease development in this laboratory worker. Our results imply that the neutralization resistance of primary HIV may indeed be considered an escape mechanism from humoral immune control.Keywords
This publication has 49 references indexed in Scilit:
- Increased Neutralization Sensitivity and Reduced Replicative Capacity of Human Immunodeficiency Virus Type 1 after Short-Term In Vivo or In Vitro Passage through ChimpanzeesJournal of Virology, 2000
- Neutralization Escape in Human Immunodeficiency Virus Type 1–Infected Long‐Term NonprogressorsThe Journal of Infectious Diseases, 1999
- Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAScience, 1998
- Atomic structure of the ectodomain from HIV-1 gp41Nature, 1997
- Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.Journal of Clinical Investigation, 1994
- Viral Variability and Serum Antibody Response in a Laboratory Worker Infected with HIV Type 1 (HTLV Type IIIB)AIDS Research and Human Retroviruses, 1994
- MEGA: Molecular Evolutionary Genetics Analysis software for microcomputersBioinformatics, 1994
- Further characterization of an antigenic site of HIV-I gp120 recognized by virus neutralizing human monoclonal anti bodiesAIDS, 1993
- Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.Journal of Clinical Investigation, 1993
- An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodiesNature, 1989